Paclitaxel With or Without PSC 833 in Treating Patients With Metastatic Breast Cancer

Completed · Phase 2

Conditions studied: Breast Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Randomized phase II trial to compare the effectiveness of paclitaxel with or without PSC 833 in treating patients with metastatic breast cancer.

Key facts

Study ID

NCT00002937

Run by

City of Hope Medical Center

People needed

70

Starts

1996-06-01

Expected to finish

2005-11-01

Last updated by the study team

2010-01-06

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Beckman Research Institute, City of Hope — Duarte, California, United States
• USC/Norris Comprehensive Cancer Center — Los Angeles, California, United States
• University of California Davis Cancer Center — Sacramento, California, United States
• Toronto Sunnybrook Regional Cancer Centre — Toronto, Ontario, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.